Brain and Behavior (May 2024)

Clinical predictors of Alzheimer's disease‐like brain atrophy in individuals with memory complaints

  • Ahmet Alp Karakasli,
  • Esra Ozkan,
  • Melike Karacam Dogan,
  • Duygu Cap,
  • Ayca Karaosmanoglu,
  • Sevilay Karahan,
  • Nabi Zorlu,
  • Esen Saka,
  • Yavuz Ayhan

DOI
https://doi.org/10.1002/brb3.3506
Journal volume & issue
Vol. 14, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Objectives The definition and assessment methods for subjective cognitive decline (SCD) vary among studies. We aimed to investigate which features or assessment methods of SCD best predict Alzheimer's disease (AD)‐related structural atrophy patterns. Methods We assessed 104 individuals aged 55+ with memory complaints but normal cognitive screening. Our research questions were as follows: To improve the prediction of AD related morphological changes, (1) Would the use of a standardized cognitive screening scale be beneficial? (2) Is conducting a thorough neuropsychological evaluation necessary instead of relying solely on cognitive screening tests? (3) Should we apply SCD‐plus research criteria, and if so, which criterion would be the most effective? (4) Is it necessary to consider medical and psychiatric comorbidities, vitamin deficiencies, vascular burden on MRI, and family history? We utilized Freesurfer to analyze cortical thickness and regional brain volume meta‐scores linked to AD or predicting its development. We employed multiple linear regression models for each variable, with morphology as the dependent variable. Results AD‐like morphology was associated with subjective complaints in males, individuals with advanced age, and higher education. Later age of onset for complaints, complaints specifically related to memory, excessive deep white matter vascular lesions, and using medications that have negative implications for cognitive health (according to the Beers criteria) were predictive of AD‐related morphology. The subjective cognitive memory questionnaire scores were found to be a better predictor of reduced volumes than a single‐question assessment. It is important to note that not all SCD‐plus criteria were evaluated in this study, particularly the APOE genotype, amyloid, and tau status, due to resource limitations. Conclusions The detection of AD‐related structural changes is impacted by demographics and assessment methods. Standardizing SCD assessment methods can enhance predictive accuracy.

Keywords